Viridian Therapeutics Inc

NASDAQ:VRDN   1:00:00 PM EDT
22.81
-0.07 (-0.31%)
1:08:39 PM EDT: $22.81 0.00 (0.00%)
Earnings Announcements

Viridian Therapeutics Inc Reports Quarterly Net Loss Per Share, Basic And Diluted Of $0.86

Published: 11/14/2022 13:29 GMT
Viridian Therapeutics Inc (VRDN) - Viridian Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Updates.
Viridian Therapeutics Inc Qtrly Net Loss per Share, Basic and Diluted $0.86.
Revenue is expected to be $0.55 Million
Adjusted EPS is expected to be -$0.75

Next Quarter Revenue Guidance is expected to be $0.49 Million
Next Quarter EPS Guidance is expected to be -$0.80

More details on our Analysts Page.